Regulus Therapeutics

1 follower


Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.

Industries

Headquarters

Stage

Employees

Links

Org chart

Jay Hagan
President & CEO

Jay Hagan

Collapse
Preston S. Klassen
President & Head of Reserach & Development
Christopher Aker
SVP & General Counsel
Rekha Garg
SVP, Clinical Development & Regulatory
Claire Padgett
SVP, Clinical Operations
Amin Kamel
VP, Drug Metabolism & Pharmacokinetics
Brian Campion
VP, Business Development
Moh Ahmadian
VP, Chemistry & Pharmaceutical Development
Edmund Lee
VP, Translational Medicine